Status:
COMPLETED
Hyperbaric Oxygen Therapy as a Neuroprotective Modality in Pediatric Acquired Brain Injury With Motor Disability
Lead Sponsor:
Kafrelsheikh University
Conditions:
Hyperbaric Oxygen Therapy
Neuroprotective
Eligibility:
All Genders
4-12 years
Phase:
NA
Brief Summary
This study aimed to assess the efficacy of hyperbaric oxygen therapy as a neuroprotective intervention in children with acquired brain injury.
Detailed Description
Pediatric acquired brain injury (ABI) represents a significant challenge in modern medicine, necessitating innovative therapeutic approaches to enhance recovery and minimize long-term neurological def...
Eligibility Criteria
Inclusion
- Age 4-12 years.
- Diagnosed with pediatric acquired brain injury confirmed by neurological examination and magnetic resonance imaging.
- Presence of neurological sequelae (e.g., cardiac arrest, intracranial hemorrhage, central nervous system infection, stroke, tumor, hypoxia).
Exclusion
- Positive family history of degenerative brain insults.
- Behavioral problems.
- Contraindications to hyperbaric oxygen therapy :
- Active epilepsy.
- Respiratory insufficiency.
- Uncontrolled heart failure.
- Eustachian tube dysfunction.
- Tympanic membrane rupture.
- Mechanical ventilation dependency.
Key Trial Info
Start Date :
March 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06954389
Start Date
March 1 2024
End Date
October 1 2024
Last Update
May 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kafrelsheikh University
Kafr ash Shaykh, Kafrelsheikh, Egypt, 33516